Obesity and Asthma: Implementing a Treatable Trait Care Model

被引:1
作者
Mendes, Francisca Castro [1 ,2 ,3 ]
Garcia-Larsen, Vanessa [4 ]
Moreira, Andre [1 ,2 ,3 ,5 ]
机构
[1] Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal
[2] Univ Porto, Lab Invest Integrat & Translac Saude Populac ITR, Porto, Portugal
[3] Univ Porto, Fac Med, Dept Pathol, Basic & Clin Immunol Unit, Porto, Portugal
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Human Nutr, Baltimore, MD USA
[5] Ctr Hosp Univ Sao Joao, Serv Imunoalergol, Porto, Portugal
关键词
asthma; body mass index; obesity; treatable trait; weight loss interventions; GESTATIONAL WEIGHT-GAIN; GLUCAGON-LIKE PEPTIDE-1; BODY-MASS INDEX; FATTY-ACIDS; SYSTEMIC INFLAMMATION; PHYSICAL-ACTIVITY; LUNG-FUNCTION; HEALTH; ADULTS; DIET;
D O I
10.1111/cea.14520
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Recognition of obesity as a treatable trait of asthma, impacting its development, clinical presentation and management, is gaining widespread acceptance. Obesity is a significant risk factor and disease modifier for asthma, complicating treatment. Epidemiological evidence highlights that obese asthma correlates with poorer disease control, increased severity and persistence, compromised lung function and reduced quality of life. Various mechanisms contribute to the physiological and clinical complexities observed in individuals with obesity and asthma. These encompass different immune responses, including Type IVb, where T helper 2 cells are pivotal and driven by cytokines like interleukins 4, 5, 9 and 13, and Type IVc, characterised by T helper 17 cells and Type 3 innate lymphoid cells producing interleukin 17, which recruits neutrophils. Additionally, Type V involves immune response dysregulation with significant activation of T helper 1, 2 and 17 responses. Finally, Type VI is recognised as metabolic-induced immune dysregulation associated with obesity. Body mass index (BMI) stands out as a biomarker of a treatable trait in asthma, readily identifiable and targetable, with significant implications for disease management. There exists a notable gap in treatment options for individuals with obese asthma, where asthma management guidelines lack specificity. For example, there is currently no evidence supporting the use of incretin mimetics to improve asthma outcomes in asthmatic individuals without Type 2 diabetes mellitus (T2DM). In this review, we advocate for integrating BMI into asthma care models by establishing clear target BMI goals, promoting sustainable weight loss via healthy dietary choices and physical activity and implementing regular reassessment and referral as necessary. Integrating BMI into asthma care models involves establishing clear target BMI goals, promoting sustainable weight loss interventions through healthy dietary choices and physical activity and implementing regular reassessment and referral as necessary.image
引用
收藏
页码:881 / 894
页数:14
相关论文
共 167 条
  • [11] Gestational weight gain, birthweight and early-childhood obesity: between- and within-family comparisons
    Badon, Sylvia E.
    Quesenberry, Charles P.
    Xu, Fei
    Avalos, Lyndsay A.
    Hedderson, Monique M.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2020, 49 (05) : 1682 - 1690
  • [12] Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up
    Baltieri, Leticia
    Cazzo, Everton
    de Souza, Aglecio Luiz
    Alegre, Sarah Monte
    Vieira, Rodolfo de Paula
    Antunes, Edson
    de Mello, Glaucia Coelho
    Martins, Luiz Claudio
    Chaim, Elinton Adami
    [J]. RESPIRATORY MEDICINE, 2018, 145 : 48 - 56
  • [13] Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation
    Bantula, Marina
    Roca-Ferrer, Jordi
    Arismendi, Ebymar
    Picado, Cesar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 21
  • [14] Obesity increases the prevalence and the incidence of asthma and worsens asthma severity
    Barros, R.
    Moreira, P.
    Padrao, P.
    Teixeira, V. H.
    Carvalho, P.
    Delgado, L.
    Moreira, A.
    [J]. CLINICAL NUTRITION, 2017, 36 (04) : 1068 - 1074
  • [15] Visceral adipose tissue: A clue to the obesity-asthma endotype(s)?
    Barros, R.
    Delgado, L.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2016, 22 (05) : 253 - 254
  • [16] Dietary patterns and asthma prevalence, incidence and control
    Barros, R.
    Moreira, A.
    Padrao, P.
    Teixeira, V. H.
    Carvalho, P.
    Delgado, L.
    Lopes, C.
    Severo, M.
    Moreira, P.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (11) : 1673 - 1680
  • [17] Optimal Asthma Control: Time for a New Target
    Beasley, Richard
    Braithwaite, Irene
    Semprini, Alex
    Kearns, Cilein
    Weatherall, Mark
    Pavord, Ian D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (12) : 1480 - 1487
  • [18] Overweight, obesity, and incident asthma - A meta-analysis of prospective epidemiologic studies
    Beuther, David A.
    Sutherland, E. Rand
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (07) : 661 - 666
  • [19] Gender differences in the perception of asthma respiratory symptoms in five Latin American countries
    Borges, Rodrigo C.
    Alith, Marcela B.
    Nascimento, Oliver A.
    Jardim, Jose R.
    [J]. JOURNAL OF ASTHMA, 2022, 59 (05) : 1030 - 1040
  • [20] Addressing sex and gender to improve asthma management
    Boulet, Louis-Philippe
    Lavoie, Kim L.
    Raherison-Semjen, Chantal
    Kaplan, Alan
    Singh, Dave
    Jenkins, Christine R.
    [J]. NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2022, 32 (01)